Taro Pharma Said To Order Warfarin Recall Over Quality Issues
This article was originally published in PharmAsia News
Executive Summary
Taro Pharmaceutical Industries, the U.S. arm of Sun Pharmaceutical Industries, reportedly has ordered a recall of its Warfarin Sodium anti-clotting drug in the wake of U.S. FDA findings of quality failures.